or
Bookmark and Share
Radiopharmaceutical formulations having non-stannous reductants
 
   
Document Number
US Patent 5662882
Issued Date
September 2, 1997
Link
Inventors
DeRosch; Mark A. (St. Charles, MO)
Deutsch; Edward A. (Maryland Heights, MO)
Map
Abstract
The present invention relates to novel radiopharmaceutical imaging agents having non-stannous reductants. The present invention further relates to kits for forming radiopharmaceutical imaging agents, such kits including non-stannous reducing agents.
Tags:
Description:
Amusing 0%
Clever 0%
Complex 0%
Efficient 0%
Historic 0%
Important 0%
Innovative 0%
Interesting 0%
Practical 0%
Simple 0%
Number of Claims:
7
Comments:
no comments yet
Owner
Published
September 2, 1997
Application Number
08/410,642
Filed
March 23, 1995
US Classification
424/1.11   424/1.65 424/1.77
Int'l Classification
A61K   51/12   (20060101)   A61K   51/02   (20060101)   A61K   51/04   (20060101)  
Assistant Examiner
Parent Case
This is a continuation of Ser. No. 08/040,739 filed on Mar. 31, 1993, now abandoned.
USPTO Field of Search
424/1.11   424/1.65   424/1.77  
Related Patents
6979431 - Method for labelling technetium or rhenium using borohydride exchange resin - Owned by Korea Atomic Energy Research Institute (Daejeon,KR)

A method for labelling a sulfide compound with technetium or rhenium, comprising the reaction of a disulfide compound with pertechnetate or perrhenate in the presence of borohydride exchange resin to obtain a complex of technetium or rhenium with the sulfide compound. The method can directly label disulfide compounds with technetium or rhenium, can skip the synthetic step of thiol-protected S-precursor, and is useful for high value-added radiopharmaceuticals.

Claims
Description
About| FAQs| Terms & Disclaimer| Link to Us| Contact Us